Log In
    ZOMDF
    $0.11
    (-5.08%)
    FLWS
    $3.29
    (2.17%)
    ACCO
    $2.85
    (-1.04%)
    ARLP
    $28.18
    (0.04%)
    AUIAF
    $0.14
    (0%)
    AZZ
    $127.11
    (0.58%)
    BTBT
    $1.38
    (0.36%)
    BTM
    $2.66
    (22.94%)
    CVKD
    $4.5
    (-4.26%)
    LCE:CA
    $0.38
    (0%)
    COCP
    $1.41
    (-6.95%)
    CDRO
    $8.55
    (0.59%)
    CVGI
    $3.95
    (10.95%)
    LODE
    $3.5
    (-2.09%)
    CMTL
    $3.69
    (3.94%)
    CNDT
    $1.42
    (1.8%)
    CXW
    $20.23
    (-1.37%)
    CMLS
    $0.01
    (0%)
    DRCT
    $0.8
    (4.97%)
    DLHC
    $5.58
    (-1.06%)
    SSP
    $3.88
    (6.25%)
    ELDN
    $3.15
    (2.61%)
    EVC
    $3
    (-0.5%)
    EDRY
    $19.8
    (0.1%)
    ESEA
    $67.6
    (0.48%)
    FAT
    $0.16
    (0%)
    RAIL
    $8.33
    (1.22%)
    GDEV
    $14.38
    (-3.46%)
    GOVX
    $1.29
    (-3.01%)
    GOCO
    $1.28
    (0.39%)
    GHM
    $81.84
    (0.73%)
    GLDD
    $0
    (0%)
    GYRE
    $6.87
    (1.33%)
    HMENF
    $1.99
    (0.96%)
    III
    $3.97
    (0.25%)
    IPOOF
    $12.78
    (1.11%)
    KELYA
    $8.78
    (0%)
    KTOS
    $73.01
    (8.47%)
    LUCK
    $8.64
    (0.58%)
    MAIA
    $1.28
    (-3.76%)
    MGROF
    $0.42
    (9.78%)
    NTRB
    $3.57
    (-1.77%)
    OCGN
    $1.79
    (0%)
    PERF
    $1.65
    (-2.37%)
    QMCI
    $0.14
    (0%)
    RGP
    $3.68
    (0%)
    SGA
    $11.49
    (-2.71%)
    SHWZ
    $0
    (900%)
    SHIP
    $13.87
    (-0.96%)
    SLQT
    $0.61
    (1.2%)
    SKYX
    $1.16
    (0.43%)
    SNAL
    $0.53
    (2.94%)
    GEO
    $18.1
    (-1.74%)
    ODP
    $28
    (0%)
    TNXP
    $13.76
    (-1.01%)
    TSQ
    $5.64
    (-0.96%)
    TZOO
    $5.93
    (0.59%)
    UNCY
    $6.77
    (-2.31%)
    VVX
    $70.71
    (1.38%)
    VNCE
    $2.37
    (0%)
    XELB
    $1.57
    (16.3%)
    ZOMDF
    $0.11
    (-5.08%)
    FLWS
    $3.29
    (2.17%)

    channelchek-in

    ‌
    4/6/2026

    Neurocrine to Acquire Soleno Therapeutics, Expanding Rare Disease and Endocrinology Portfolio

    The acquisition adds VYKAT™ XR (diazoxide choline), the first and only FDA-approved treatment for hyperphagia in Prader-Willi syndrome (PWS), to Neurocrine’s growing portfolio of first-in-class therapies.

    0
    4 min read
    • ‌
      Noble Capital Markets Research Morning Call

      Noble Capital Markets Research Morning Call

      Today’s Noble Capital Markets equity research reports, available with free...

      144 min read

    • No Cuts, No Ceasefire, No Clarity: The Macro Wall Investors Are Staring Down

      3 min read

    • Receive FREE Research, News, Video, and Event Updates in Your Inbox!

    • The Pharma Tariff Playbook: How Drug Companies Can Navigate the Administration’s Latest Pricing Push

      3 min read
    View all

    News

    4/6/2026

    Release – Townsquare Announces Conference Call to Discuss First Quarter 2026 Results

    3 min read
    ‌
    Release – Townsquare Announces Conference Call to Discuss First Quarter 2026 Results
    4/6/2026

    Release – NeuroSense Granted Brazilian Patent Covering PrimeC Composition

    5 min read
    ‌
    Release – NeuroSense Granted Brazilian Patent Covering PrimeC Composition
    4/6/2026

    Release – The Oncology Institute Names Minh Merchant Chief Legal Officer

    2 min read
    ‌
    Release – The Oncology Institute Names Minh Merchant Chief Legal Officer
    4/6/2026

    Release – Snail Games Expands Portfolio with Publishing Agreement for Co-op Party Action Title Dead Party

    4 min read
    ‌
    Release – Snail Games Expands Portfolio with Publishing Agreement for Co-op Party Action Title Dead Party
    View all

    Research Reports

    Cocrystal Pharma (COCP) – CDI-988 Receives Fast Track Designation, Raising Its ProfileCP(Ocugen (OCGN) – Dosing Completed Early In The OCU410ST Phase 2/3 GARDian TrialO(DNutriband (NTRB) – First Marketing Partnership Expands Territory and Brings A Product ApprovalN(FSummit Midstream Corp (SMC) – Private Placement Financing Strengthens Balance Sheet and Enhances Financial FlexibilitySMC(
    View all

    Video Content

  • ‌
    ZenaTech Inc.

    ZenaTech Inc.

    Conference Presentation
    2/5/2026
  • ‌
    VivoPower International PLC

    VivoPower International PLC

    Conference Presentation
    2/5/2026
  • ‌
    IN8bio Inc.

    IN8bio Inc.

    Conference Presentation
    2/5/2026
  • ‌
    Star Equity Holdings Inc.

    Star Equity Holdings Inc.

    Conference Presentation
    2/5/2026
    • View all

    Movers

    Symbol
    Change
    SMX
    73.82%
    MAXN
    62.35%
    CLIR
    43.17%
    AIB
    38.36%
    RCMT
    36.79%
    View all
    Log In